2022 News Articles

All | 2022 | 2021 | 2020 | 2019

This month’s Research Highlights focuses on provider and patient beliefs about mammogram screening frequency, and separately, provider barriers to engaging in shared decision-making with high-risk patients about the use of... Read More

POSTED: 11/28/2022
SOURCE: Cancer Prevention Science Blog

An image of a medical technician reviewing a mammogram seen on computer screen.

The National Cancer Institute Division of Cancer Prevention has released three Funding Opportunity Announcements to accept applications to create the Cancer Screening Research Network (CSRN).  The CSRN will conduct rigorous... Read More

POSTED: 11/21/2022
SOURCE: DCP News

CSRN Funding Announcements Published. ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1), Coordinating and Communication Center (UG1), Statistics and Data Management Center (UG1)

Cervical cancer can be prevented by human papillomavirus (HPV) vaccination and by screening for and treating precancerous lesions. Yet, millions of women globally remain at high-risk for developing cervical cancer. This is... Read More

POSTED: 11/14/2022
SOURCE: Cancer Prevention Science Blog

CASCADE's 4 Focus Areas

Cancer Biomarkers Research Group, Division of Cancer Prevention The National Cancer Institute (NCI) is seeking a Program Director to lead an innovative portfolio of research focused on biomarkers for cancer early detection... Read More

POSTED: 11/10/2022
SOURCE: DCP News

Office of the Director, Division of Cancer Prevention The National Cancer Institute (NCI) is seeking a Program Director to lead an innovative portfolio of research focused on symptom management, palliative care, and quality... Read More

POSTED: 11/02/2022
SOURCE: DCP News

CP-CTNet Newsletter - September 2022

Featured Article: CP-CTNet Cross Network Study: Lynch Syndrome.  Inherited susceptibility to cancer involves defects in genes that normally function to suppress the formation of tumors. One such syndrome was recognized by... Read More

POSTED: 09/30/2022
SOURCE: CP-CTNet DMACC Website

Screen capture of the CP-CTNet September 2022 Newsletter

More than half of cancer survivors who were treated with chemotherapy for the four most common types of cancer experienced clinically significant hearing loss and tinnitus after treatment, according to new research. The... Read More

POSTED: 09/27/2022
SOURCE: Cancer Prevention Science Blog

In this study, more than 50% of cancer survivors treated with platinum- or taxane-containing chemotherapies were found to have significant hearing loss and tinnitus after treatment.

Welcome to ULACNet Update, where we share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page As we... Read More

POSTED: 09/23/2022
SOURCE: DCP News

ULACNet Update

Recruitment has begun for a clinical study that investigators hope will move “liquid biopsy” technology closer to its still-distant goal: a single blood test for the early detection of cancer. Collectively known as multi-... Read More

POSTED: 09/15/2022
SOURCE: Cancer Prevention Science Blog

An image of a research holding a blood sample in a test tube.

Research Highlights are a new type of blog for Cancer Prevention Science, where recent publications are highlighted rather than a traditional news story. This month’s blog post highlights how a cruciferous vegetable extract... Read More

POSTED: 08/24/2022
SOURCE: Cancer Prevention Science Blog

An image of cruciferous vegetables.

In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old.... Read More

POSTED: 08/10/2022
SOURCE: Cancer Prevention Science Blog

Cover of Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs

CP-CTNet Newsletter - July 2022

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More

POSTED: 07/22/2022
SOURCE: CP-CTNet DMACC Website

Cover of the July 2022 issue of the CP-CTNet Newsletter

Unlike many other cancers, the incidence and death rates for uterine cancer are rising. Rates of new uterine cancer cases have risen 0.6% per year from 2010-2019, and death rates have risen an average of 1.7% per year for... Read More

POSTED: 06/28/2022
SOURCE: Cancer Prevention Science Blog

An example of a nonendometrioid cancer.

‘The complexities are staggering.’ U.S. plans huge trial of blood tests for multiple cancers

National Cancer Institute prevention chief discusses steps toward largest U.S. cancer screening trial ever Read More

POSTED: 06/22/2022
SOURCE: Science Magazine

A gloved hand lifting a test tube of a blood sample from a rack.

Key Messages Although aspirin use has been studied for decades, there are still many gaps in our understanding its role in cancer prevention. Risk-benefit analyses should be conducted to ensure that the right patients are... Read More

POSTED: 06/15/2022
SOURCE: DCP News

In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type... Read More

POSTED: 05/06/2022
SOURCE: Cancer Prevention Science Blog

Established Risk Factors for Developing Female Breast Cancer

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page The... Read More

POSTED: 04/28/2022
SOURCE: DCP News

ULACNet-301 participant receiving first study vaccine.

Screening for Many Cancers with One Test: Uncertainty Abounds

One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately determine whether and where in the body a person has early-stage cancer.... Read More

POSTED: 04/21/2022
SOURCE: NCI Cancer Currents Blog

Illustration of biomarkers that are released by cancer cells or induced by their presence.

Overall, cancer death rates in the United States have been declining about 2% per year, current SEER data from 2014 through 2018 show. However, these improvements have not been experienced equally by everyone, which is one... Read More

POSTED: 04/18/2022
SOURCE: Cancer Prevention Science Blog

Precision cancer screening and prevention strategies: population risk, biological risk, modality, delivery

Can Cancer Blood Tests Live Up to Promise of Saving Lives?

Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET... Read More

POSTED: 04/11/2022
SOURCE: AP News

April 8-13, 2022 DCP/PREVENT-funded Project Presentations Session OPO.IM01.01 - Tumor Immunobiology 5631 - Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous... Read More

POSTED: 04/01/2022
SOURCE: DCP News

AACR Annual Meeting 2022

CP-CTNet Newsletter - March 2022

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More

POSTED: 03/31/2022
SOURCE: CP-CTNet DMACC Website

Screen capture of the cover of CP-CTNet March 2022 Newsletter.

Press Release: Enrollment in TMIST Breast Cancer Screening Trial Surpasses Halfway Mark; Recruitment of Women from Diverse Backgrounds is Key to Success

Philadelphia, March 25, 2022 — The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), is more than halfway to its recruiting goal of 128,905 participants with more than 20% of participants in the United States being... Read More

POSTED: 03/25/2022
SOURCE: ECOG-ACRIN Press Release

A group of women from diverse backgrounds.

RESEARCH UPDATE: ON THE CLINICAL FRONT Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Colon Adenoma Patients Preclinical studies suggest calcium, vitamin D, and vitamin D... Read More

POSTED: 03/18/2022
SOURCE: DCP News

An image of foods high in calcium, vitamin D, and vitamin D receptors.

Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat... Read More

POSTED: 02/09/2022
SOURCE: Cancer Prevention Science Blog

An illustration displaying signal amplification.

Study Identifies Potential Drug Target to Prevent Some Liver Cancers

While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C... Read More

POSTED: 02/04/2022
SOURCE: NCI Cancer Currents Blog

Illustration showing progression from normal liver to nonalcoholic steatohepatitis.

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page... Read More

POSTED: 01/28/2022
SOURCE: DCP News

Partial screen grab of the ULACNet Zoom meeting showing a grid 9 participants.

Even If Insured, People with Advanced Cancer Often Face Financial Problems

Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study. Read More

POSTED: 01/26/2022
SOURCE: NCI Cancer Currents Blog

Photo of a health insurance statement.

Key Messages There are many screening questions that can be addressed through clinical trials. One size doesn’t fit all: There is a trend for increasingly personalized screening, where cancer screening recommendations are... Read More

POSTED: 01/25/2022
SOURCE: DCP News

A meeting of statistical leads from the seven NCI Community Oncology Research Program (NCORP) Research Bases with statisticians from the Division of Cancer Prevention (DCP) Biometry Research Group took place on July 16, 2021... Read More

POSTED: 01/20/2022
SOURCE: DCP News

Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited. In the United States, almost 60% of people... Read More

POSTED: 01/14/2022
SOURCE: Cancer Prevention Science Blog

An illustration of a displaying a bronchoscopy, entering via nasal swabs to detect a suspicious nodule.